Glutathione (GSH)
Also known as: GSH · L-Glutathione · Reduced glutathione
Clinical IV is supervised in approved settings; cosmetic IV has documented serious AE signal (Philippines FDA 2011); regulatory varies sharply by region.
Rating per Panya's data-first method, not regulator endorsement. The mechanism, dose, and risk sections below carry the underlying data.
Glutathione is an endogenous tripeptide (glutamate, cysteine, glycine) that every cell makes. IV glutathione is widely sold across Southeast Asian wellness clinics for skin lightening and antioxidant support; the clinical evidence is mixed and the regulatory posture varies sharply by region.
Last reviewed · Panya.health editorial
Panya scores vendors against an 11-signal rubric. Vendors at or above 70 out of 100 are routable; below 70 are documented but get no Panya affiliate link. For prescription peptides like Mounjaro and Wegovy, Panya routes today through licensed clinicians. For research peptides like Glutathione (GSH), vendor scorecards land in a follow-up sprint after legal review and payment processor selection. Until then, the page surfaces commonly-mentioned vendor names so adults can do their own diligence. We do not yet earn commission on any Glutathione (GSH) vendor.
Not medical advice. Glutathione (GSH) is not approved for human medical use in most jurisdictions. The data below is what users do; it is not what regulators have validated. You decide your risk profile.
What it does, and how
Glutathione is the body's primary intracellular antioxidant. Reduced glutathione (GSH) donates an electron to neutralise reactive oxygen species, becoming oxidised glutathione (GSSG); glutathione reductase recycles it back. It also drives Phase II conjugation in the liver, neutralising electrophilic drug metabolites including paracetamol's NAPQI (which is why N-acetylcysteine, a glutathione precursor, is the antidote for paracetamol overdose). Skin-lightening claims rest on the secondary mechanism that GSH inhibits tyrosinase and shifts melanin synthesis from eumelanin (dark) toward pheomelanin (light); this is documented in vitro and in some small clinical trials, but the effect size and durability are debated.
Typical practice
Clinical IV glutathione for hepatic support typically runs 600 to 2400 mg per session, 1 to 3 times weekly. Cosmetic IV glutathione for skin tone in Southeast Asian clinics commonly runs 1200 to 5000 mg per session, often combined with vitamin C, sometimes daily for weeks. Oral glutathione has poor bioavailability because it gets broken down in the gut; liposomal and S-acetyl glutathione formulations show improved pharmacokinetics in published studies (Richie 2015). Nebulised glutathione is studied for cystic fibrosis. No regulator-approved dose exists for the skin-lightening use case; the cosmetic-IV doses above reflect what clinics use, not trial-validated protocols.
The dosing above is community practice, not a regulator-validated protocol. Trial-validated dosing for Glutathione (GSH) in humans does not exist for most use cases listed.
Risks and contraindications
Clinical IV glutathione has a favourable safety profile in supervised hepatology and oncology adjunct settings published in the literature. The Philippines FDA 2011 advisory documented deaths and serious adverse events linked to high-dose IV glutathione for skin lightening (Stevens-Johnson syndrome, toxic epidermal necrolysis, anaphylaxis, kidney injury); quality control on IV solutions outside hospital pharmacies appears in the case reports as the main attributable factor. In vitro and case-report findings: prolonged tyrosinase inhibition reduces protective melanin and may raise UV sensitivity (Sonthalia 2016); IV glutathione has triggered bronchospasm in case reports of asthmatic patients. No trial data exists in pregnancy, lactation, or paediatric cohorts. Long-term cosmetic IV use is not characterised in the literature.
Where this stands legally
FDA-approved nebulised glutathione exists for cystic fibrosis under specific compounding rules; IV glutathione for cosmetic use is not approved. Compounding pharmacies sell IV preparations under physician orders; the FDA has issued letters discouraging cosmetic IV glutathione marketing.
MHRA treats injectable glutathione as a prescription medicine. Cosmetic IV use is not authorised; some private clinics offer it off-label under physician supervision, with import scrutiny on unlicensed preparations.
EMA has not approved IV glutathione for cosmetic use. Some member states (Italy, Greece) tolerate compounded IV glutathione under prescription; others restrict it. Oral glutathione is sold as a food supplement.
TGA Schedule 4 (prescription-only) for injectable forms. Personal-import restrictions apply. Oral and liposomal glutathione are sold as complementary medicines.
Widely sold IV at private wellness clinics in Bangkok, Phuket, Chiang Mai, often without specialist medical supervision. Thai FDA has issued public warnings about cosmetic IV glutathione but enforcement is uneven; the practical reality is that supply is plentiful and quality varies.
HSA classifies injectable glutathione as a prescription medicine. Sold legally only through licensed clinics with physician supervision. Imports of unlicensed cosmetic IV preparations have been seized at the border.
Sold IV at private spas and wellness clinics across Ho Chi Minh City and Hanoi. Vietnam Drug Administration has limited enforcement scope on cosmetic use; quality and source vary widely.
Common at private wellness clinics serving the expat market. Indonesian BPOM has cautioned against cosmetic IV use but enforcement is light. Source quality is the main risk vector.
Where users say they source it
Names below are sourced from community discussion. None are currently scored against the Panya 11-signal rubric. Panya does not earn commission on any of these. You can search them yourself; treat the list as a starting point for your own diligence, not an endorsement.
- Hospital and clinic IV pharmacies (Bumrungrad, Samitivej, BNH, Bangkok Hospital, etc.)Pending Panya 11-signal audit
- Private wellness clinics in Bangkok, Phuket, BaliPending Panya 11-signal audit
- Compounding pharmacies (US, EU, AU, with prescription)Pending Panya 11-signal audit
- Liposomal and S-acetyl oral formulations from supplement brands (variable quality, COA on lot strongly recommended)Pending Panya 11-signal audit
Full vendor scorecards for Glutathione (GSH) land in a follow-up sprint after lawyer review and payment processor selection. We will not route users to any vendor that scores below 70 on the rubric.
Papers worth reading directly
- Sechi G et al. (1996) Reduced intravenous glutathione in Parkinson's disease →
- Hauser RA et al. (2009) Randomized trial of IV glutathione in Parkinson's →
- Sonthalia S, Daulatabad D, Sarkar R (2016) Glutathione as a skin whitening agent: facts, myths, evidence and controversies →
- Philippines FDA Advisory 2011 on high-dose IV glutathione for skin lightening →
- Richie JP Jr et al. (2015) Randomized controlled trial of oral glutathione supplementation →
Adjacent reading
Track Glutathione (GSH) in your peptide journal.
Panya users log their full stack at panya.health/journey. Public-by-default with per-entry privacy controls. Vote-validated by the community.